Company / Current Liabilities per Share
GYRE THERAPEUTICS, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.21
FY2025
5-year range
$0.16 / $0.64
FY2021-FY2025
Trend
-16.8%
vs FY2024
Sector context
#189 of 210
Health Care
What the data says
Among 210 Health Care companies, GYRE THERAPEUTICS, INC. is in the top 10% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.16 in FY2022 to $28.19 in FY2016.
Based on SEC 10-K filings.
0.21 in FY2025 with a 5-year CAGR of -32.2%.
Improved from $0.32 to $0.21 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- -32.2%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 210This company $0.21 Sector average $15.78
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 16.8% year-over-year.
- Ranks #189 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2016.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -16.8% |
| FY2024 | $0.25 | -19.2% |
| FY2023 | $0.32 | +94.9% |
| FY2022 | $0.16 | -74.8% |
| FY2021 | $0.64 | -56.6% |
| FY2020 | $1.48 | -38.9% |
| FY2019 | $2.42 | +206.2% |
| FY2018 | $0.79 | -69.1% |
| FY2017 | $2.55 | -90.9% |
| FY2016 | $28.19 | -78.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026